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Epistasis among Presynaptic Serotonergic System Components
Scott F. Stoltenberg
Department of Psychiatry, University of Michigan Addiction Research Center, Ann Arbor, Michigan
Present address (2004): Department of Psychology, Black Hills State University, Spearfish, South Dakota

Abstract
Epistatic interactions among regulatory components of the serotonin (5-HT) neurotransmitter system may
be an important aspect of 5-HT function. Because 5-HT dysregulation is associated with several common
psychiatric disorders, the potential for epistasis among genetic variants in the 5-HT transporter (SERT),
5-HT1B terminal autoreceptor and the 5- HT1A somatodendritic autoreceptor should be examined. In this
study, output from a dynamic minimal model of 5-HT function was compared to empirical results in the
literature. Parameters representing extracellular 5-HT clearance rates (SERT), 5-HT release levels (5-HT1B)
and inhibitory thresholds (the amount of extracellular 5-HT above which cell firing is inhibited, an indication of 5-HT1A autoreceptor sensitivity) were varied to simulate genetic deletion (i.e., knockout) of each
component singly, and in combination. Simulated knockout effects on extracellular 5-HT level and presynaptic neural firing rates were in the same direction and of similar relative magnitude as studies in the
literature. Epistasis among presynaptic components appears to be important in the 5-HT system’s regulation of extracellular 5-HT levels, but not of firing rates.
Keywords: Dynamic systems, epistasis, knockout, serotonin, SERT, 5-HT1A, 5-HT1B.

cludes epistasis has the potential to improve psychiatric treatment by providing a theoretical framework
for genetically individualized therapy based on pharmacogenetic profiling (Lesch, 2002).
The terms physiological or mechanistic epistasis
describe a situation wherein the effect on a phenotype of a particular allele at a locus depends on the
allelic state of one or more other loci (Brodie, 2000).
Such epistatic interactions are likely in traits with
complex genetic architectures and blur the distinction between ‘‘major’’ and ‘‘minor’’ genetic effects
because the effect of a given allele on a phenotype
is not a property of that allele, but is context dependent (Templeton, 2000). Physiological epistasis does
not appear to be rare, and in fact, in the genetic architecture of common human diseases, epistasis may be
ubiquitous (Moore, 2003). Therefore, it is reasonable
to seek evidence for epistasis in physiological systems

Introduction
It is important to improve our understanding of how
the serotonin (5-HT) system is controlled because it is
involved in the etiology of common psychiatric disorders such as depression (Blier and de Montigny,
1998), obsessive compulsive disorder (Baumgarten and Grozdanovic, 1998), schizophrenia (Aghajanian and Marek, 2000) and alcoholism Heinz et al.,
2001; Hill et al., 1999). It is likely that certain combinations of common genetic variants confer different
risk profiles and treatment prognoses for their carriers than do other combinations and that such gene–
gene interactions may be more important in common
disorders than are main effects of any single gene
(Moore, 2003). A more complete understanding of
the relations among genetically varying system components in the regulation of 5-HT function that in199
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where components interact; and the 5-HT system is a
good candidate system in which to seek evidence of
epistasis because it is comprised of multiple, interactive components that vary genetically and because 5HT dysfunction is associated with risk for common
psychiatric disorders (Veenstra-VanderWeele et al.,
2000).
Experimental strategies that use lines of mice with
genetic deletions (i.e., knockouts) have been employed to investigate the contribution of serotonin
transporters (Gobbi et al., 2001; Mannoury la Cour
et al., 2001), 5-HT1A somatodendritic (He et al., 2001;
Knobelman et al., 2001a, b; Parsons et al., 2001; Richer
et al., 2002) and 5-HT1B terminal autoreceptors (de
Groote et al., 2002; Evrard et al., 1999; Knobelman et
al., 2001a, b; Malagie et al., 2002) to the regulation of
5-HT function. Studies using in vivo microdialysis (de
Groote et al., 2002; He et al., 2001; Knobelman et al.,
2001a, b; Malagie et al., 2002; Parsons et al., 2001) and
single unit cell recording Evrard et al., 1999; Gobbi et
al., 2001; Mannoury la Cour et al., 2001; Richer et al.,
2002) have provided valuable data on extracellular 5HT concentration and cell firing rates, respectively.
Although there is evidence that the effects of each
component may not be the same in different brain regions (Knobelman et al., 2001a, b; Malagie et al., 2002),
it is clear that the 5-HT transporter (SERT) and the autoreceptors contribute to 5-HT regulation. Studying
knockout mice has provided substantial suggestive
evidence for epistatic effects on traits influenced by 5HT function when components are jointly examined
by genetic deletion and/ or pharmacological manipulation (de Groote et al., 2002; Evrard et al., 1999; Gobbi
et al., 2001; He et al., 2001; Knobelman et al., 2001a, b;
Malagie et al., 2002; Murphy et al., 2001; Parsons et al.,
2001).
A negative feedback framework is generally accepted to underlie the regulation of the 5-HT system
(Aghajanian and Sanders-Bush, 2002); however, a
systematic quantitative examination of such a model
has not been carried out with computer simulation.
In this study, I present a quantitative model of negative feedback regulation of presynaptic 5-HT function
and compare simulation-generated results with extant empirical results from the literature. This model
is not intended to simulate the function of single neuron; rather, it is a ‘‘top down’’ look at the regulation
of the central 5-HT system. In a sense, this model may
be considered a caricature of how genetically varying
components in the 5-HT system may influence indices of 5-HT function. As with all caricatures, it is in-
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tended to capture the essence of the subject in broad
strokes, not to replicate the subject in minute detail.
Variables in the simulation modeled genetic deletion
of SERT, somatodendritic 5-HT1A and terminal 5-HT1B
autoreceptors. The simulation incorporates dynamic
rules to adjust somatodendritic autoreceptor sensitivity and terminal autoreceptor mediated 5-HT release
amounts. The purpose of this study, was to examine
the general hypothesis that presynaptic 5-HT function
is influenced by epistatic interactions among SERT
and the somatodendritic 5-HT1A and terminal 5-HT1B
autoreceptors. Comparing simulation results with microdialysis and single- unit recording results from the
empirical literature should determine whether this
interactive, dynamic, three-component model of presynaptic 5-HT control is sufficient to capture the dynamics of 5-HT regulation.

Method
Software
Because system dynamics models are well suited to
analyze biological control systems (Gallaher, 1996)
this model was implemented using Berkeley Madonna 8.0.1 (Zahnley, 2000); a commercially available
simulation tool. The simulation was conducted by
numerically solving differential equations. The code
used to generate data is included in the Appendix 1.
The Model
Perhaps the most intuitive way to describe the model
is by referring to the component parts and behavior of
a single neuron. However, it should be kept in mind
that for the present model the level of analysis is conceptualized as the central 5-HT system consisting of
tens of thousands of neurons originating in the raphe
nucleus and projecting to most brain areas (Baumgarten and Gothert, 1999).
Vesicular releases triggered by action potentials introduce serotonin into the extracellular compartment
(see Figure 1). Aspects of serotonin release are determined by terminal (1B) and somatodendritic (1A)
autoreceptors. Somatodendritic autoreceptors determine whether the system releases any serotonin
(i.e., whether the system ‘‘fires’’) based on a comparison of the level of extracellular serotonin to an inhibitory threshold. If the level of extracellular serotonin
exceeds the inhibitory threshold the somatodendritic
autoreceptors inhibit system firing (i.e., no serotonin
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is released). Conversely, if the level of extracellular
serotonin is below the inhibitory threshold the somatodendritic autoreceptors permit firing. Based on
this firing decision the threshold is adjusted to either
increase or decrease receptor sensitivity such that if
the system has just fired, the threshold is decreased
to make it less likely that the system will fire at the
next time step; whereas if the system did not fire, the
inhibitory threshold is increased to make firing more
likely at the next time step. Genetic variation at the
5-HT1A autoreceptor is assumed to affect the rate at
which changes in sensitivity occur.
When the system fires, the amount of serotonin to
be released into the extracellular compartment for
that particular time step is determined by the terminal (1B) autoreceptor. For normal functioning, it is assumed that the terminal autoreceptor adjusts the release amount according to the level of serotonin in
the extracellular compartment. That is, when extracellular serotonin levels are high, less serotonin is released, and when levels are low, more serotonin is released. Genetic variation at the 5-HT1B autoreceptor is
assumed to eliminate such responsiveness to the level
of serotonin in the extracellular compartment so that
level of serotonin released remains constant.
Serotonin flows out of the extracellular compartment by transporter mediated reuptake and by diffusion. Reuptake and diffusion are modeled to remove
a proportion of the serotonin in the extracellular compartment at each time step. For normal functioning
it is assumed that reuptake removes 90% of the serotonin in the extracellular compartment and that diffusion removes the remaining 10%. Genetic variation in
serotonin transporter (SERT) function is assumed to
reduce the reuptake percentage. The rate of diffusion
is assumed to be constant.
Extracellular 5-HT
Serotonin enters the extracellular compartment by
way of vesicular release and is removed actively by
reuptake and passively by diffusion. The dynamics of
extracellular 5-HT (Y) is characterized by
dY/dt = ρ – (υY + δY)

(1)

where Y denotes the amount of 5-HT in the extracellular compartment, ρ represents the rate at which 5-HT
added to the extracellular compartment (e.g., via vesicular release), and υ represents the rate at which 5-HT is
removed from the extracellular compartment via reuptake, and where δ represents rate of diffusion.
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Figure 1. Dynamic model of presynaptic 5-HT system regulation: Y denotes extracellular 5-HT level, ρ denotes the
release rate, υ denotes the reuptake rate, δ denotes the diffusion rate and T denotes the inhibitory threshold. See text
for a detailed explanation of the model and for equations.

Somatodendritic Autoreceptor
When the level of 5-HT in the extracellular compartment exceeds an inhibitory threshold somatodendritic autoreceptors (i.e., 5-HT1A) inhibit neural firing.
In this simulation, it is assumed that 5-HT1A autoreceptors dynamically adjust their inhibitory thresholds such that 5-HT neurons maintain a characteristic, regular firing rate across a range of extracellular
5-HT levels. The dynamic inhibitory threshold in this
negative feedback loop is characterized by
dT/d = T + A

(2)

where T denotes the inhibitory threshold (in 5-HT
units) and A represents a conditional adjustment
factor, based on whether the system ‘‘fired’’ (i.e., released 5-HT). The equation for the adjustment factor
is characterized by
A(t) =

{

κ if ρ = 0,
λ if ρ > 0

(3)

where κ > 0, that is, κ increases the inhibitory threshold, making it more likely that the system will fire at
the next time step; and λ < 0, that is, λ decreases the
inhibitory threshold, making it less likely that the system will fire at the next time step.
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We defined the inhibitory threshold (T) as the
amount of extracellular 5-HT above which presynaptic 5-HT neural firing is inhibited. That is, T represents the sensitivity of somatodendritic autoreceptors.
Initial T values are set below the level of the average release value because it was reasoned that firing
should be inhibited if the amount of neurotransmitter remaining in the extracellular space was equal to
or greater than the average release amount. This assumes that for proper neurotransmission a substantial amount of neurotransmitter must be cleared from
the extracellular space before another firing event is
permitted to occur.

the synapse the system would be inhibited firing at
the next time step. The exact value of T(initial) = 50 was
arbitrary.
The other outcome variable of primary interest was
‘‘Firing Rate’’ defined as the number of times that the
system fired (i.e., released 5-HT) divided by the number of time steps. For each model condition, extracellular 5-HT Level and firing rate were recorded after
50,000 time steps. Because randomness was not built
into the model, one run for each condition was sufficient to produce outcomes that may be considered the
true values of those indices (i.e., additional runs under the same conditions produced identical values).

Terminal Autoreceptor

Model Verification

Terminal autoreceptors (i.e., 5-HT1B) influence the
amount of 5-HT released per release event. In this
model the amount of 5-HT to be released is a function of a constant baseline release value (B) that is
corrected with respect to the amount of 5-HT in the
extracellular compartment (i.e., is inversely proportional to). Therefore, terminal autoreceptor regulation
of release is characterized by

To verify that the model is doing what is expected,
the following approach was taken. First, parameter
plots were generated for each outcome variable across
ranges of an independent variable (e.g., reuptake rate)
and these were inspected for conceptual coherence.
Next, the baseline outcomes for the model were established by performing a run of 50,000 time steps.
Then for each of the parameters of interest (SERT [S],
5-HT1A [A]; 5-HT1B [B]) we set each to simulate a loss
of function due to genetic deletion (i.e., knockout, see
Table I). Results were compared to those in the empirical literature with respect to direction and magnitude of effect.

ρ=

[(

) ]

B
ÄC
Y+1

(4)

where B represents a constant release value (50) and
Y denotes amount of 5-HT in the extracellular compartment. To avoid having a zero in the denominator,
Y + 1 is used. To achieve reasonable release values a
correction factor is used, where C is a constant (100).
Outcome Measures
Level of extracellular 5-HT was an outcome variable
of primary interest. For each simulation run the initial starting level of extracellular 5-HT (i.e., Y(0)) was
set at 50. Parameter plots that varied the initial level
of 5-HT from 0 to 500 had no effect on outcome variables. Parameter plots that varied the initial inhibitory threshold (T) from 0 to 500 had no effect on EXSER, but increased SERFIRE Rate (ratio of times fired
to time steps) linearly from 0.49 to 0.59 (data not
shown). The initial value for T (50) was chosen so
that at baseline the system maintained a regular firing rate (around 0.50) and with tight regular oscillations around the inhibitory threshold, and because
it was assumed that the initial inhibitory threshold
should be below the average release value so that if
most of the 5- HT from a single release remained in

Data Analysis and Statistics
The effects of manipulating reuptake rate (i.e., SERT
KO), 5-HT1A somatodendritic autoreceptor function
(i.e., 5-HT1A KO) and 5-HT1B terminal autoreceptor
function (i.e., 5-HT1B KO) on simulated extracellular
5-HT level and firing rate were examined. The effect

Table I. Model parameters.
			
Knockout Genotype
Variable
SERT
S–/A+/B+
		
5-HT1A
S+/A–/B+
		
5-HT1B
S+/A+/B–

Baseline
value

KO
value

Reuptake
0.90
0.00
rate (υ)
Threshold
adjustment (λ) –5
–1
Release (ρ)
[(B/Y+1) Ä C] 100

B represents a release constant, set at 50, and C represents an
adjustment factor set at 100. Y represents the amount of 5-HT
detected in the extracellular compartment.
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assess interaction through visual inspection of the
output in line figures. Departures from parallel indicate the presence of interaction. For the Figures, the
baseline extracellular 5-HT level (Exser) and firing
rate (Serfire) were set to 100% and knockout values
are shown relative to baseline.

Results
Parameter Plots

Figure 2. Parameter plots generated by varying one parameter while holding others at baseline level. Each graph shows
curves for extracellular 5-HT level (Exser, black square) and
presynaptic system firing rate (Serfire, white square). Baseline
level was set to 100%. Parameter plots are shown for (a) reuptake rate simulating variation in 5-HT transporter function, (b)
threshold adjustment simulating variation in 5-HT1A somatodendritic autoreceptor function, (c) release constant simulating variation in 5-HT1B terminal autoreceptor function.

of each simulated condition was examined independently, as well as in logical combinations with the
other conditions (i.e., double and triple knockouts).
For statistical analyses, raw data were used. The
Mann–Whitney test used to examine single gene effects. Although the outcome measures are accurate
population parameters, assessing the effect of knocking out a single gene in this study required the comparison of two groups, each with N = 4. Rank order
methods seemed preferable to parametric methods
for such comparisons. For the multiple knockout conditions, visual inspection of histograms was used to
assess epistatic interactions. Interactions were not formally tested because of concerns regarding the power
of non-parametric statistical tests to detect interactions when the total N = 8. However, because the outcome values can be considered population parameters (i.e., no uncertainty) it seemed reasonable to

Parameter plots were generated to assess change in
level of extracellular 5-HT (Exser) and system firing
rate (Serfire) across the range of a single parameter
(see Figure 2).
Varying the reuptake rate had no substantial effect
on Serfire, but did affect Exser (see Figure 2a). Reducing reuptake is known to increase extracellular levels
of 5-HT and temporarily reduces firing rate. Down
regulation or desensitization of somatodendritic autoreceptors (5-HT1A) allows neural firing at higher
levels of extracellular 5-HT and this dynamic model
captures this adaptation as shown by the high levels
of Exser at low uptake rates and firing rates that are
little changed relative to baseline.
The threshold adjustment λ represents antagonism
of the 5-HT1A autoreceptor that inhibits firing when
activated, therefore, blocking an inhibitory function
would raise the inhibitory threshold (i.e., allowing the
system to fire at elevated levels of extracellular 5-HT).
Reducing λ permits system firing at higher Exser levels thereby resulting in higher Exser levels and higher
rates of firing [see Figure 2(b)]. Recall that κ raises
the inhibitory threshold, while λ lowers it. When κ
> λ, the inhibitory threshold rises faster than it falls,
which results in higher levels of the inhibitory threshold overall.
Varying the release constant (B) has no effect on
Serfire, but is positively associated with Exser (see
Figure 2c). It is logical that higher rates of release will
increase Exser levels when all other variables remain
constant.
The behavior of the model, as shown in these parameter plots, is consistent with expectations, thereby
achieving a basic level of model verification (Rykiel,
1996).
Baseline Levels
Running the model with the baseline values given
in Table I produced an extracellular 5-HT level of
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49.38 units, and a firing rate of 0.50 (i.e., 25,000 firings/50,000 time steps). The raw values were then set
to 100% to facilitate visual comparisons with the simulated knockout conditions.
Knockouts
To examine the effect of genetic deletion of components in this minimal model of presynaptic 5- HT
function, baseline values were systematically replaced with the knockout values shown in Table I
to simulate seven knockout conditions (three single,
three double, and one triple knockout). For the analysis of single gene effects, the Mann–Whitney test was
used (Table II).
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was not significant U = 6.5, p = .66. Mean Serfire rank
for the 5-HT1B knockout conditions was (B– = 4.13)
and for the functional 5-HT1B conditions it was (B+ =
4.88).
Multiple Knockouts
In order to identify potential gene–gene interactions
on the level of extracellular 5-HT (Exser) the results
of simulation runs are shown in Figure 3. Results for
the wild type (+) and knockout (–) alleles for both the
5-HT1A (A) and 5-HT1B (B) autoreceptors are shown in
combination and grouped by SERT (S) genotype. The
values shown are relative to the baseline (S+/A+/B+)
condition, which is set to 100%. Little variation is seen
across A and B genotypes in the S+ condition. However, in the S– condition, substantial increases in Exser

Single Knockouts
For Exser, the main effect of SERT knockout was significant, U = 0.00, p = .02. Mean Exser rank for the
SERT knockout conditions (S– = 6.5) was higher
than mean Exser for the functional SERT conditions
(S+ = 2.5). For Serfire, the main effect of SERT knockout was not significant, U = 4.0, p = .25. Mean Serfire
rank for the SERT knockout conditions was (S– = 3.5)
and for the functional SERT conditions it was (S+ =
5.5). Consistent with the parameter plot results, reducing reuptake rate (i.e., knockout out SERT function) increased levels of extracellular 5-HT and produced essentially no change in firing rates. Firing
inhibition is initially observed in the SERT knockout condition (data not shown). However, because
the inhibitory threshold dynamically responds to
changes in 5-HT levels, the firing rates after 50,000
time steps are not significantly reduced relative to
non-knockout conditions.
For Exser, the main effect of 5-HT1A knockout was
not significant, U = 5.00, p = .39. Mean Exser rank
for the 5-HT1A knockout conditions was (A– = 5.25)
and for the functional 5-HT1A conditions it was (A+ =
3.75). For Serfire, the main effect of 5-HT1A knockout
was significant U = 0.00, p = .02. Mean Serfire rank
for the 5- HT1A knockout conditions (A– = 6.5) was
higher than mean Serfire rank for the functional 5HT1A conditions (A+ = 2.5).
For Exser, the main effect of 5-HT1B knockout was
not significant, U = 5.00, p = .34. Mean Exser rank
for the 5-HT1B knockout conditions was (B– = 5.25)
and for the functional 5-HT1B conditions it was (B+ =
3.75). For Serfire, the main effect of 5-HT1B knockout

Table II. Effects of genetic deletion or pharmacological agents
on 5-HT level and 5-HT cell firing rates in empirical literature.
Knockout

Genotype

5-HT
Level

Firing
rate Citation

Single
S–/A+/B+ ↑↑
↓/0
				
				
				
				
				
S+/A–/B+ 0/↑
↑
				
				
				
S+/A+/B– 0
0/↓
				
				

de Groote et al., (2002),
Evrard et al., (2002),
Gobbi et al., (2001),
Knobelman et al., (2001b),
Malagie et al., (2002) and
Mannoury la Cour et al., (2001)
He et al., (2001),
Knobelman et al., (2001),
Parsons et al., (2001) and
Richer et al., 2002
de Groote et al., (2002),
Evrard et al., (1999),
Knobelman et al., (2001)

Double
S–/A–/B+
↑↑↑
↑
				
				
				
				
S–/A+/B–
↑↑↑
↓/0
				
				
				
				
S+/A–/B–
?
?

Gobbi et al., (2001),
He et al., (2001),
Knobelman et al., (2001),
Knobelman et al., (2001),
Parsons et al., (2001)
de Groote et al., (2002),
Evrard et al., (1999),
Knobelman et al., (2001),
Knobelman et al., (2001),
Malagie et al., (2002)
None

Triple

Knobelman et al., (2001)

S–/A–/B–

↑↑↑

?

S– = SERT KO, A– = 5-HT1A KO, B– = 5-HT1B KO. Increases are indicated by arrows: 100–200%=↑, 200–600%=↑↑, over 600% = ↑↑↑; Decreases are indicated by ↓. No change is indicated by 0. No report in
literature = ?. When no knockout data was available in the literature,
data from pharmacological challenge studies was used (most often in
double and triple knockout conditions).
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Figure 3. Simulated levels of extracellular 5-HT for conditions defined by 5-HT transporter (S), 5-HT1B (B) and 5-HT1A
(A) genotypes. The wild-type state is indicated by (+) and the
knockout state is indicated by (–). Baseline (S+/B+/A+) is set
to 100%. Differences in the pattern of B/A genotype effects
across S genotype groups are evidence of epistatic interaction
among components for extracellular 5-HT level.

Figure 4. Simulated rates of presynaptic 5-HT firing for conditions defined by 5-HT transporter (S), 5-HT1B (B) and 5-HT1A
(A) genotypes. The wild-type state is indicated by (+) and the
knockout state is indicated by (–). Baseline (A+/S+/B +) is set
to 100%. Parallel lines across A genotype groups indicates that
there is no epistatic interaction among components for firing
rate.

are observed such that knocking out A and B augments the Exser increase seen in the S knockout, and
the triple knockout produces the highest observed
Exser levels. Different patterns of results between the
S+ and S– groups suggest that epistatic interactions
among SERT and the 1A and 1B autoreceptors influence extracellular 5-HT levels.
In order to identify potential gene–gene interactions on firing rate (Serfire) the results of simulation
runs are shown in Figure 4. Results of the S and B
knockout conditions are grouped by A genotype. The
two lines are parallel which suggests that that SERT
and the 1A and 1B autoreceptors do not interact to influence rates of 5-HT neural firing.

clearance rates alone. The highest levels of extracellular 5-HT were achieved in the triple knockout condition. Knocking out the function of the 5HT1A somatodendritic autoreceptor in the simulation produced
higher system firing rates, but did not substantially
affect levels of extracellular 5-HT. Knocking out the
only function of the 5-HT1B terminal autoreceptor in
the simulation did not affect extracellular 5-HT levels
or firing rates. However, when the 5-HT1B terminal
autoreceptor was knocked out in combination with
other components the resulting patterns of extracellular 5- HT level suggested significant epistatic interaction. These simulation results are consistent with the
empirical literature on knockout mice.
In wild-type mice, SSRI treatment raised extracellular levels of 5-HT to 200–300% of baseline (de
Groote et al., 2002; He et al. 2001; Malagie et al., 2002;
Parsons et al., 2001); and extracellular 5-HT enhancement is expected, but has not been reported in SERT
knockout mice. The extracellular 5-HT enhancing effects of SSRI administration were augmented in 5HT1A and 5-HT1B knockout mice, relative to wild
type, as well as in wild-type mice treated with a 5HT1A or 5-HT1B antagonist (de Groote et al., 2002; He
et al., 2001; Knobelman et al., 2001a, b). These same
patterns of results were observed in the present simulation study, if one assumes similarity, on a gross
level, of SERT KO and SSRI treatment. Both reduce
5-HT reuptake, although constitutive knockouts result in developmental effects that acute SSRI treatment do not (Salichon et al., 2001). Another difference
that can be seen between constituative knockouts and

Discussion
The main finding of the present study is that an oversimplified, top down, dynamic model of 5- HT system regulation reproduced important aspects of 5HT function, and that simulation results suggest that
epistasis among system components may influence
aspects of system function, specifically extracellular
5-HT level. The simulation results were largely consistent with recent empirical results from microdialysis and electrophysiological studies in mice. Reducing
clearance rates, which in the model simulates the reduction of SERT function by genetic deletion, raised
extracellular 5-HT levels. Knocking out the 5-HT1A
and/or 5-HT1B autoreceptors in the SERT knockout augmented the observed increase in extracellular 5-HT that resulted from reducing SERT mediated
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acute SSRI treatment in the firing rate of 5-HT neurons. Complete firing inhibition can be achieved with
SSRI treatment (Evrard et al., 1999, 2002), whereas genetic deletion of SERT produces 5-HT firing rates that
are either no different than wild type (Mannoury la
Cour et al., 2001), or somewhat reduced (Gobbi et al.,
2001). Desensitization of somatodendritic 5-HT1A autoreceptors in SERT knockouts permits firing of 5-HT
neurons (Gobbi et al., 2001), and it is thought that this
dynamic change in autoreceptor sensitivity may underlie the therapeutic delay observed in SSRI treatment for depression, though the exact mechanism is
not completely characterized (Hensler, 2002).
Simulation results showed a modest increase in 5HT level in the 5-HT1A KO condition (129% of baseline value), in contrast to the results of several empirical studies where extracellular 5-HT levels in 5-HT1A
knockout mice are not different from that observed
in wild-type mice (de Groote et al., 2002; Evrard et al.,
2002; He et al., 2001; Knobelman et al., 2001b; Richer et
al., 2002), although a modest increase in extracellular
5-HT was reported in one study Parsons et al., 2001).
It may be that this discrepancy is a signal that there
is some misspecification in the theoretical model underlying the simulation (e.g., lack of a relevant adaptation mechanism or less than optimal parameter values) or to differences in extracellular 5-HT level that
are below the threshold of detection of the microdialysis techniques used. It is also possible that epistatic
interactions among 5-HT1A mutant alleles and one or
more unmeasured background alleles might mask the
effect of the genetic deletion Palmer et al., 2003).
There are some limitations of the simulation that
should be considered. Expression or functional differences among different brain regions in terminal autoreceptors (Fabre et al., 2000; Knobelman et al., 2001a,
b; Malagie et al., 2002), somatodendritic autoreceptors (Fabre et al., 2000; Knobelman et al., 2001a, b;
Mannoury la Cour et al., 2001), or transporters Montanez et al., 2002) were not considered in this simulation. The model also did not address 5-HT synthesis,
metabolism or post-synaptic effects. However, given
that the simulation produced output with a high degree of consistency with empirical observations, such
shortfalls do not appear to detract from the potential
usefulness of the model for understanding global aspects of 5-HT regulation.
The relation of the time steps in the model to real
time units is not immediately obvious. Microdialysis
and single-unit recording measurements are usually
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performed on quite different time scales and not simultaneously in the same animal. In the simulation,
the first few time steps (approximately 20 or 30) capture the firing inhibition mediated by the 5- HT1A autoreceptors; whereas the values reported in this study
are those observed at time step 50,000 well after dynamic adjustments to the inhibitory threshold have
taken place (i.e., equilibrium has been established).
Run time parameters in the present model could be
optimized to fit particular time scales, however, it
seems that the real contribution of this model is to
provide a flexible platform for thinking about and
generating hypotheses about the relations among system parameters and outcomes.
Comparing the simulation results to empirical results from the literature identifies several instances
where directional hypotheses can be made to fill in
gaps in the empirical literature. We were unable to
identify empirical data for comparison to the results
for 5-HT firing rates in 5-HT1A and 5-HT1B double
knockouts, but the simulation results suggest that the
firing rates of 5-HT neurons would be elevated (167%)
as would levels of extracellular 5-HT (169%) relative
to wild type. In a triple KO mouse, results from the
simulation predict that firing rates of 5-HT neurons
would be elevated (167%) relative to wild type. In
each of these cases, the simulation results can serve
as directional hypotheses to be tested with microdialysis or electrophysiology studies in mice. Such studies will further test the validity of the present model
of presynaptic 5-HT regulation. Generation of testable hypotheses is an important aspect of simulation
(Gallaher, 1996). This model of 5-HT function could
also be used to simulate human genetic variation by
using less extreme parameter values than were used
here to simulation genetic deletion (Montanez et al.,
2003). The simulation could also be used to examine the effects of pharmacological agents that act at
the three presynaptic 5-HT components examined in
the model. In an extension to the model, we examined the effects of a common SERT promoter variant (5-HTTLPR) on 5-HT and dopaminergic function
in the context of pharmacological treatment for alcoholism (Stoltenberg, 2003). Other extensions of this
model are being planned to address some of its current shortcomings, including the addition of an early
life stress variable, because of the important of early
life stress in 5-HT function and in traits influenced by
5-HT (Caspi et al., 2003; Huizink et al., 2004; Vazquez
et al., 2002).
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How does this modeling approach fit into the
larger context of theoretical neuroscience? Neuroscientists have been using computational models to
study aspects of brain function since the mid twentieth century. Broadly, the areas of investigation can
be lumped into two categories: single cells and networks (for an excellent overview of the field see the
Nature Neuroscience Supplement Volume 3, November 2000). Decades of progress in computational neuroscience has resulted in exquisitely sophisticated
biophysical models of neural firing (bottom–up) and
network models of cognition (top–down). However,
little emphasis has been placed on understanding the
role of genetic variation in producing differences in
the functioning of neural systems. The present model
lies somewhere in between models of single neurons and neural networks and utilizes a dynamic
systems approach that has a long history in its own
right and has been used to study the workings of the
brain (von Bertalanffy, 1968; Wiener, 1961). The hope
is that by using computational techniques we can arrive at a better understanding of how heredity influences behavior.
How important is it to understand epistatic interaction in the 5-HT system? If epistasis is a fundamental feature of 5-HT functioning, then the genetic
architectures for the myriad psychiatric disorders associated with 5-HT dysfunction must include gene–
gene interactions. Traditional approaches to identify
genes underlying single gene disorders may not be
suitable to identify genes in the presence of epistasis,
which may explain some of the difficulty in identifying genes for psychiatric disorders (Williams et al.,
2004). If epistasis is ubiquitous in common human
diseases (Moore, 2003), new approaches will be required to study their etiology.

Conclusion
This simulation of 5-HT regulation captures many important aspects of 5-HT function including epistasis.
Epistatic interaction among presynaptic system components appears to be an important feature of the 5HT system’s regulation of 5-HT levels, and therefore
should be considered in studies that seek to understand the influence of 5-HT system genetics on behavior. The use of simulations should enable hypothesis
generation and help to crystallize our understanding
of an important neurotransmitter system.
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Appendix 1
Berkeley–Madonna 8.0.1 Code for Epistasis Model
INTEGRATION METHOD = EULER’S
STARTTIME = 0
STOPTIME = 50,000
DT = 0.01
{Reservoirs}
d/dt (EXSER) = + ser_in – ser_out
INIT EXSER = 50
d/dt (SERFIRE) = + serFireRate
INIT SERFIRE = 0
d/dt (IThreshold) = + threshAdjust
INIT IThreshold = 50
Flows
ser_in = IF EXSER > IThreshold THEN 0 ELSE R
ser_out = (REUPTAKE_RATE*EXSER) +
(DIFFUSION*EXSER)
serFireRate = IF ser_in > 0 THEN 1 ELSE 0
threshAdjust = IF serFireRate = 0 THEN AU ELSE AD
{Functions}
AU = 5
R = IF HT1B= 1 THEN (B/(EXSER+1))*100 ELSE (2*B)
B = 50
REUPTAKE_RATE = 0.90
DIFFUSION = 0.1
HT1B = 1
AD = –5
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